Thomas M. Clements, Dds, Inc. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 3006 State Highway 49 Ste D, Cool, CA 95614 Phone: 530-888-6079 |
News Archive
VIVUS, Inc. today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The REVIVE-Diabetes study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the International Index of Erectile Function (IIEF) score.
Despite increased use of total hip arthroplasty (THA) and total knee arthroplasty (TKA), there is a notable lack of consensus about optimal postoperative treatment. Aquatic therapy has been shown to have a beneficial effect, and it is typically begun two weeks after surgery, after the wound has healed.
Researchers at the Salk Institute for Biological Studies have discovered a powerful mechanism by which viruses such as influenza, West Nile and Dengue evade the body's immune response and infect humans with these potentially deadly diseases. The findings may provide scientists with an attractive target for novel antiviral therapies.
MedShape, Inc., the industry leader in innovative shape memory orthopedic devices, today announced the company received U.S. Food and Drug Administration 510(k) clearance for its Eclipse Soft Tissue Anchor, a new shape memory fixation device designed to attach a tendon, ligament or soft tissue to bone.
› Verified 8 days ago